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Anticancer Activities of Plant Secondary Metabolites: Rice 
Callus Suspension Culture as a New Paradigm 
Wusirika RAMAKRISHNA1, #, Anuradha KUMARI1, #, Nafeesa RAHMAN2, Pallavi MANDAVE3 
(1Department of Biochemistry, Central University of Punjab, Bathinda, Punjab 151001, India; 2Department of Biological Sciences, 
Michigan Technological University, 1400 Townsend Drive Houghton, Michigan 49931, USA; 3Interactive Research School for 
Health Affairs, Bharati Vidyapeeth, Pune, Maharashtra 411043, India; #These authors contributed equally to this work) 
Abstract: Plant natural products including alkaloids, polyphenols, terpenoids and flavonoids have been 
reported to exert anticancer activity by targeting various metabolic pathways. The biological pathways 
regulated by plant products can serve as novel drug targets. Plant natural compounds or their derivatives 
used for cancer treatment and some novel plant-based compounds which are used in clinical trials were 
discussed. Callus suspension culture with secondary metabolites can provide a continuous source of 
plant pharmaceuticals without time and space limitations. Previous research has shown that rice callus 
suspension culture can kill > 95% cancer cells with no significant effect on the growth of normal cells. The 
role of candidate genes and metabolites which are likely to be involved in the process and their potential 
to serve as anticancer and anti-inflammatory agents were discussed. Large scale production of plant 
callus suspension culture and its constituents can be achieved using elicitors which enhance specific 
secondary metabolites combined with bioprocess technology. 
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Cancer is the leading cause of mortality after 
cardiovascular diseases. Cancer incidence increases 
with age with > 75% new cases among the age group 
of 55 years and above (White et al, 2014). Numbers of 
estimated cancer cases in USA in 2019 are 268 600, 
228 150, 174 650, 145 600 and 73 820 for breast, lung, 
prostate, colorectal and renal cancers, respectively 
(American Cancer Society, 2019). Numbers of estimated 
deaths due to cancer in USA are 142 670, 51 020, 41 760, 
31 620 and 14 770 for lung, colorectal, breast, prostate 
and renal cancers, respectively. Cancer is an inherited 
or sporadic complex genetic disease due to various 
modifications in gene expression (Wishart, 2015). 
These modifications can be in the forms of point 
mutations, insertions, deletions, transpositions and 
translocation resulting in uncontrolled proliferation, which 
is the hallmark of cancer. 
Proto-oncogenes and tumor suppressor genes are 
the two categories of genes that conventionally undergo 
alterations (Lee and Muller, 2010). In cancer, the 
expression of tumor suppressor genes is inhibited, and 
proto-oncogenes are upregulated by various mutations. 
These pro-oncogenic alterations help the mutated cell 
to bypass every checkpoint of cell division, ultimately 
invading and spreading to the neighboring tissues. 
Metastasis is initiated by the formation of new blood 
vessels from existing vessels called angiogenesis. 
Various factors responsible for the mutation of normal 
cell to cancer cell include exposure to asbestos, tobacco, 
drugs, radiation and oncogenic viruses, ultimately 
resulting in an alteration in the genetic makeup of the 
cell. In comparison to normal cells, cancer cells exhibit 
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nuclear pleomorphisms, chromosomal abnormalities, 
reduction in the cellular gap junction and increase in 
motility. They possess inherent growth signals, which 
make them resistant to growth suppression signals. 
They manifest resistance to apoptosis, a programmed 
cell death that is necessary for maintaining the 
homeostasis between cell growth and cell death in the 
body (Fulda, 2009). These properties of a cancer cell 
are possible targets for drug development with a focus 
on halting cell growth, invasion and progression. 
Over the years, an enormous number of drugs have 
been synthesized and used to either prevent or cure 
cancer (Cragg and Pezzuto, 2016). However, their 
untoward systemic adverse effects on patients, the 
rapid development of drug resistance and higher cost 
of treatment are some of the drawbacks rendering 
them ineffective in overall cancer management. As a 
result, despite advances in the development of synthetic 
oncogenic drugs, cancer patients are increasingly 
dependent on alternative medicines for treatment due 
to their safety, availability, affordability, minimal adverse 
effects and less chance of developing resistance. Plants 
are the only source of medicine in ancient times (Petrovska, 
2012; Pan et al, 2014). Surprisingly, they remain a 
significant source of medicine till now, predominantly 
in developing countries due to their advantages over 
commercial synthetic drugs. World Health Organization 
(WHO) has reported that about 80% of the world 
population still relies on the herbal mode of therapy 
than conventional synthetic drugs (WHO, 2014). 
Cancer researchers have therefore focused their 
attention more on natural products as an alternative 
source of cancer control and cure. Ancient Atharva 
Veda and Ayurveda of India, Papyrus of Egypt and 
traditional Chinese medicine provide rich documentations 
of plant-based preventive and curative methods of 
ailments and diseases (Lemonnier et al, 2017). Several 
parts of plants like stems, barks, roots, leaves, seeds 
and their extracts are used as herbal drugs (Li and 
Weng, 2017). About 60% of the prescribed anticancer 
drugs in use are derivatives of plant metabolites. 
Paclitaxel (Pacific yew), camptothecin (Camptotheca 
acuminata), vincristine and vinblastine (Madagascar 
periwinkle) and etoposide (Podophyllum) or their 
water-soluble analogs are some examples of well- 
known plant-derived anticancer products (Fridlender 
et al, 2015; Howes, 2018). Several other promising 
plant natural compounds with anticancer activity and 
their modes of action are described in Lichota and 
Gwozdzinski (2018). 
Rice serves as a staple food for majority of the world’s 
population. Although the content of total phenolics 
and flavonoids of black rice and red rice varieties is 
higher than the white rice varieties in most cases, some 
exceptions are observed (Shen et al, 2009; Chutipaijit 
and Sutjaritvorakul, 2018). Rice and its byproducts 
such as bran and husk harbor phenolic compounds 
(ferulic acid and p-coumaric acid), phytic acid, tocopherols 
and tocotrienols, which act as chemopreventive agents 
(Tan et al, 2017; Yu et al, 2019).  
The synthesis of plant secondary metabolites by 
plant tissue culture is independent of environmental 
conditions (Smetanska, 2008). Plant cell culture system 
offers a unique opportunity for the large scale production 
of anticancer compounds due to their industrial level 
scalability and the advantage over human and bacterial 
cell cultures due to the lack of human pathogens and 
bacterial endotoxins (Xu and Zhang, 2014). Several 
pharmaceutical proteins including serum albumin and 
taliglucerase alfa are produced using carrot, tobacco 
and rice cell cultures as well as (Yao et al, 2015). 
Although callus cultures have been used to produce 
targeted natural products, there is very little information 
on the use of plant callus suspension culture as a 
cytotoxic or anticancer agent. Callus suspension culture 
and callus extracts of rice and desert cotton, respectively 
have been shown to be cytotoxic to cancer cells (Deshpande 
et al, 2012; Rahman et al, 2016; Kamalanathan and 
Natarajan, 2018).  
The major objectives of this review were to provide 
an update on plant secondary metabolites with 
anticancer activity, the use of plant callus suspension 
cultures for in vitro production of secondary metabolites 
and the potential application of rice callus suspension 
culture with secondary metabolites as an anticancer 
agent. Further, the biological pathways regulated by 
secondary metabolites including those found in rice 
callus suspension culture were discussed. 
Secondary metabolites and their anticancer 
effects 
Secondary metabolites are not essential for the growth 
and development of plants, but they have important 
accessory activities such as help in defense against 
herbivory, growth inhibition of competing plants, 
bacterial and fungal pathogens and aiding in 
pollination. They possess various anti-inflammatory 
and anti-oxidant activities (Adebayo et al, 2015). 
Anti-oxidant capabilities include termination of free  
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radical chains and chelation of redox active metal ions 
that cause lipid peroxidation. These properties also 
help with cancer prevention. Secondary metabolites of 
plants are grouped into alkaloids, terpenoids, polyphenols 
and flavonoids based on their structures (Singh et al, 
2016). Notable anticancer alkaloids include vinblastine, 
vincristine and camptothecin; terpenoids include lycopene 
and gamma-tocopherol; polyphenols include etoposide, 
resveratrol, curcumin and epigallocatechin gallate 
(EGCG); and flavonoids include apigenin, genistein 
and kaempferol. These bioactive compounds exert 
anticancer effects either independently or synergistically 
with other compounds through regulation of metabolic 
and signaling pathways, inhibition of enzymes vital 
for cancer progression, angiogenesis, microtubule 
assembly and inducing apoptosis (Kojima-Yuasa et al, 
2015). Over the years, several plants and plant extracts 
are being studied for their antiproliferation properties, 
Table 1. In vitro examples of plant bioactive compounds and their molecular targets. 
Phytochemical (Source) (Dose) Cancer type Mode of action and its target Reference 
Apigenin (sorghum) and quercetin 
(cowpea) (0.1 μmol/L)  
Caco-2 cell model and non-cancer 
CCD-18Co cell line 
Activity of efflux transporters in Caco-2 modified by 
inhibiting expression of ABC transporters, BCRP, 
MRP2, MRP3 and MDR1 
Agah, 2016 
Altholactone (Goniothalamus sp.) 
(10, 20 and 40 μmol/L) 
LNCaP, PC-3 and DU-145 
prostate cancer cells 
Inhibited STAT3 and NF- B transcription  Jiang et al, 2017
Curcumin (Curcuma longa)  
(20 μmol/L) 
Colorectal cancer cell lines Suppressed the Sp-1 activation and its downstream 
genes, ADEM10, calmodulin, EPHB2, HDAC4 and 
SEPP1 




Hepatic, colorectal and pancreatic 
cancer cell lines 
Modulated CDK5, glucocorticoid signaling and ERK/ 
MAPK signaling, mediated by the activation of 
CDKN1A, SEMA3E, GADD45  and GADD45  and 





(Goniothalamus sp.)  
(300 μmol/L) 
HeLa cervical cancer, MCF-7 
breast cancer and HT-29 colon 
cancer cells 
Induced oxidative stress in cancer cells leading to 
apoptosis. Up-regulation of p53 stabilized by NQO1 
leading to caspase-2-dependent 
mitochondrial-mediated apoptosis 
Alabsi et al, 
2012; Seyed et al, 
2014 
Ursolic acid (Oldenlandia diffusa) 
(25 μmol/L) 
Lung cancer Inhibited the activity of a mitotic kinase, 
vaccinia-related kinase 1 
Kim et al, 2015
Ethanolic extract with Avicennones 
D and E (Avicennia marina) (200 
mg/kg) 
MB-231 cell induced tumor in 
nude mice 
Avicennones D and E containing ethanolic extract 
treatment decreased MMP2, MMP9, cyclin B, 
vimentin, PARP, caspase 8 and snail protein 
expression and increased caspase 3 expression 
Huang et al, 
2016 
Curcumin (Curcuma longa)  
(45 mg/kg) 
NSCLC (A549) subcutaneous 
xenograft tumor model  
Inhibited in vivo tumor growth, adiponectin and MMPs 
expression 
Tsai et al, 2015
Genistein (Glycine max)  
(500 mg/kg) 
A431 and Colo205 xenografts 
(mouse)  
Upregulated GLUT3 and downregulated ER  Honndorf et al, 
2016 
Resveratrol  
(Vitis vinifera)  
(100–1000 mg) 
Clinical trials for colorectal and 
prostate cancers 
Regulated nuclear factor B (NF- B) signaling pathway 
and p53, inhibited IGF-1R/Akt/Wnt and 
PI3K/Akt/mTOR pathways  
Berman et al, 
2017 
Usnic and salazinic acids 
(Flavocetraria cucullata extract) 
(10 μmol/L usnic acid; 5 μg/mL 
extract) 
A549 cell induced lung cancer in 
Balb/c nude mouse 
Activated apoptotic signaling pathway in vitro and 
reduced levels of phosphor-Akt 
Nguyen et al, 
2014 
Ursolic acid (Punica granatum) 
(266 mg/kg) 
Postmenopausal breast cancer 
model 
Anti-tumor effect through Akt/mTOR signaling de Angel et al, 
2010 
Withaferin A  
(Withania somnifera)  
(2 mg/kg) 
HCT116 colon cancer cells 
injected into BALB/c nude 
mouse 
Anticancer effect mediated by the inhibition of STAT3 
signaling pathway 
Choi and Kim, 
2015 
ABC transporter, ATP binding cassette transporter; ADAM10, A Disintegrin and metalloproteinase domain-containing protein 10; BCRP, Breast 
cancer resistance protein; CCNB, Cyclin B; KIF20A, Kinesin family member 20A; CCNB1, Cyclin B1; CDKN1A, Cyclin dependent kinase inhibitor 
1A; CDK5, Cyclin-dependent kinase 5; EPHB2, Ephrin type-B receptor 2; ERK, Extracellular signal-regulated kinase; ER , Estrogen receptor alpha; 
GADD45 , Growth arrest and DNA damage 45 alpha; GADD45 , Growth arrest and DNA damage 45 beta; GLUT3, Glucose transporter 3; HDAC4, 
Histone deacetylase 4; IGF-1R, Type-1 insulin-like growth factor receptor; MAPK, Mitogen-activated protein kinase; MDR1, Multidrug resistance 
protein 1; MMP2, Matrix metalloproteinase 2; MMP9, Matrix metalloproteinase 9; MRP2, Multidrug resistance protein 2; MRP3, Multidrug 
resistance protein 3; mTOR, Mammalian target of rapamycin; NSCLC, Non-small-cell lung carcinoma; NF- B, Nuclear factor kappa light chain 
enhancer of activated B cells; NQO1, NAD(P)H quinone oxidoreductase; PI3K, Phosphatidylinositol-3-kinase; PARP, Poly ADP ribose polymerase; 
SEMA3E, Semaphorin-3E; SEPP1, Selenoprotein P1; SP-1, Specificity protein 1; STAT3, Signal transducer and activator of transcription 3; TOP2 , 
Topoisomerase 2-alpha. 
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and many of them display potential ability to inhibit 
cancer growth and progression (Grothaus et al, 2010). 
Table 1 summarizes some investigated plants and their 
active components showing prominent cancer preventive 
and inhibitory effects. A comprehensive study on the 
underlying mechanism of the action of these compounds 
and other novel compounds and their interactions can 
explain the biological basis of their anticancer effects. 
Towards this goal, it is essential to understand the 
various changes in cancer physiology that differentiate 
it from a normal proliferating cell so that the side effects of 
an anticancer agent on normal cells can be prevented. 
Biological pathways serving as targets of 
plant metabolites 
The hallmark of a cancer cell is its uncontrolled rate of 
proliferation. A cancer cell alters its physiology to 
meet the nutritional and energy requirements. These 
alterations are in the form of modifications in metabolic 
pathways, signaling pathways and enzymatic regulation 
(Fig. 1). Some of the essentially crucial elements of 
these altered metabolic pathways are glucose, glutamine, 
oxygen and adenosine triphosphate (ATP) (Biswal et al, 
2017). These metabolic alterations mainly focus on 
rapid ATP production, synthesis of macromolecules 
needed for cell progression and regulation of appropriate 
redox state. In case of scarcity of nutrients and energy, 
cancer cells are able to modulate their pathways and 
continue proliferation. Genetic alterations and tumor 
microenvironment contribute to the abnormal phenotype 
of cancer. The characteristic changes in metabolism 
and pathway can serve as important targets for cancer 
therapy. The challenging task is to find a specific 
window to differentiate the proliferating cancer cells 
Fig. 1. Major players and pathways involved in cancer metabolism and their regulation by plant metabolites.  
Curcumin and other plant natural compounds regulating PI3K/Akt/mTOR pathway are shown. Adapted from Porta et al (2014), Eales et al (2016),
and Kastenhuber and Lowe (2017).
Akt, Protein kinase B; C-Myc, Cellular myelocytomatosis; 4E-BP1, Eukaryotic initiation factor 4E binding protein 1; FKBP-12, Drug FK506 binding
protein-12; GLUT, Glucose transporter; HIF-1 , Hypoxia-inducible factor-1 alpha; mTOR, Mammalian or mechanistic target of rapamycin; OCT1,
Octamer binding transcription factor-1; PDH, Pyruvate dehydrogenase; PDK, Pyruvate dehydrogenase kinase; PKM2, Pyruvate kinase M2; PTEN,
Phosphatase and tensin homolog; PI3K, Phosphatidylinositol-3-kinase; SCO2, Synthesis of cytochrome C oxidase 2; TCA cycle, Tricarboxylic acid
cycle; TIGAR, Tumor protein 53 inducible glycolysis and apoptosis regulator. 
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and proliferating normal cells. The advancement of 
analytical technology has resulted in the discovery of 
numerous cancer signaling pathways and processes 
which are specifically regulated in cancer cells and are 
important for malignant transformation (Green and 
Llambi, 2015). Warburg effect is a significant change 
in cancer metabolism, where energy production is 
diverted from the normal oxidative phosphorylation to 
aerobic glycolysis (Warburg, 1956). This shift serves 
two vital purposes: produce ATP rapidly and produce 
large quantities of substrate for the biosynthesis of 
macromolecules needed for cancer progression. This 
diversion to glycolysis makes glucose essential for 
cancer cells. It has been reported that glucose transporters 
(GLUT) are up-regulated in cancer in a cell-specific 
manner (Thorne and Campbell, 2015). Targeting 
GLUT presents a viable strategy for cancer inhibition 
and treatment. Plant extracts have been shown to target 
GLUT. For example, naringenin, a flavonoid presents 
in grapes inhibits glucose uptake in MCF-7 breast 
cancer cells by inhibiting the phosphoinositide 3- 
kinase (PI3K) pathway that regulates glucose transporter, 
GLUT4 (Harmon and Patel, 2004). Another regulator 
(inhibitor) of glucose transporter is phloretin, a polyphenol 
presents in apple which reduces tumor progression 
(Kundu et al, 2014). 
The PI3K pathway is a common pathway activated 
by mutations in genes whose protein products are 
known to modulate processes involved in cancer such 
as cell proliferation, motility, metabolism and survival 
(Broecker-Preuss et al, 2017). It is inhibited in normal 
cells by phosphatase and tensin homolog (PTEN), 
which is a tumor suppressor. PTEN has been observed 
to be mutated and suppressed in cancer cells, thereby 
activating the PI3K pathway. The well-studied downstream 
target of the PI3K pathway is AKT1 (protein kinase 
B), which mainly regulates glycolytic mechanism of 
cancer cells through the allocation of glucose transporters 
and activation of glycolytic enzymes. Flavonoids of 
various plant extracts and curcumin, a polyphenol 
from Curcuma longa, have been reported to target the 
PI3K pathway and AKT1 (Mouhid et al, 2017), thereby 
hindering uncontrolled cell proliferation associated 
with cancer. 
The mechanistic target of rapamycin (mTOR) is an 
essential pathway for the regulation of cell growth and 
proliferation. It is responsible for the synthesis of 
proteins and lipids needed for cancer cells in the 
presence of sufficient nutrition and energy (Cargnello 
et al, 2015). This pathway is activated by AKT (Porta 
et al, 2014). The mTOR pathway can serve as an 
effective target for combatting cancer. Curcumin has 
been reported to inhibit cancer progression by regulating 
the mTOR pathway (Hamzehzadeh et al, 2018). 
Hypoxia-inducible factor 1 (HIF1) is an important 
transcription factor regulating cancer proliferation, 
and is generally activated under hypoxic environment. 
It has been reported to be readily activated in cancer 
cells even under normoxic environment. In cancer, 
mTOR pathway is known to upregulate the expression 
of HIF1, which in turn upregulates enzymes involved 
in glycolysis as well as glucose transporters (Eales et al, 
2016). The hypoxic tumor microenvironment induces 
HIF1 activating enzymes to produce energy. HIF1 
also activates the expression of gene encoding 
vascular endothelial growth factor (VEGF), thereby 
promoting angiogenesis (Zimna and Kurpisz, 2015). 
Topotecan, a semisynthetic derivative of pentacyclic 
alkaloid and camptothecin, which is a metabolite of 
the Chinese yew, inhibits HIF1 in cervical cancer 
(Robati et al, 2008). Glyceollin, a phytoalexin from 
soybean, reduces the expression of HIF1, resulting in 
the inhibition of HIF1-induced genes (Lee et al, 2014). 
AMP-activated protein kinase (AMPK), the energy 
status sensor of the body, is reported to be suppressed 
by various signaling pathways and mutations in cancer. 
Activation of AMPK can, therefore, serve as a good 
target for inhibiting cancer cell proliferation and 
growth. AMPK activation leads to cell death in a P53 
dependent pathway (He et al, 2014). Oleanolic acid 
(OA), a triterpenoid presents in a number of medicinal 
plants, is reported to activate AMPK in cancer cells, 
which has been shown to suppress the growth of 
prostate cancer cell line PC-3 and breast cancer cell 
line MCF-7 (Liu et al, 2014). Curcumin has also been 
reported to induce apoptosis in ovarian tumor cell via 
activation of AMPK (Pan et al, 2008). 
P53 is known to be an important tumor suppressor, 
which is down-regulated in cancer. In a normal cell, it 
detects DNA damage and halts the cell cycle for repair 
or diverts the cell to apoptosis through caspase 
activation. P53 has been reported to up-regulate TP53- 
induced glycolysis and apoptosis regulator (TIGAR) 
(Kastenhuber and Lowe, 2017) and PTEN, thereby 
suppressing glycolysis by inhibiting PI3K pathway. 
Although it is a known tumor suppressor, P53 is also 
involved in modulating the glycolytic phenotype in 
cancer by activating the enzyme hexokinase 2, thereby 
potentiating the macromolecule synthesis in cancer 
through the pentose phosphate pathway (Simabuco et al, 
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2018). Several plant metabolites such as curcumin, 
resveratrol and quercetin induce apoptosis through the 
p53-dependent pathway (Panda et al, 2017). Most of 
the cell cycles regulated by p53 are indirect and involve 
a repressor complex, dimerization partner, RB-like, 
E2F and MuvB (DREAM) (Engeland, 2018). Efficient 
chemotherapeutic drugs can be developed by understanding 
the mechanisms by which these regulators modulate 
the cell cycle. Flavonoids like quercetin, genistein and 
flavopiridol have been reported to inhibit cyclin- 
dependent kinases (CDKs). Anthocyanins inhibit proliferation 
of cancer by blocking progression through the cell 
cycle by targeting P53, P21, cyclin D and cyclin A. 
Phytic acids from rice bran up-regulate P53 gene in 
liver cancer cells (Al-Fatlawi et al, 2014). Gamma- 
oryzanol and tricin from rice bran extracts inhibit 
G2/M phase whereas gamma-oryzanol, gamma-tocotrienol 
and phytic acid inhibit G0/G1 phase of cell cycle in 
cancer cells (Yu et al, 2019). Gamma-oryzanol also 
inhibits nuclear factor kappa light chain enhancer of 
activated B cells (NF- B) signaling pathway.  
Topoisomerase II is an important enzyme for DNA 
replication during cell division. It regulates the negative 
supercoiling of DNA downstream of the replication 
fork (Ketron and Osheroff, 2014). Topoisomerase 
covalently binds with the cleaved DNA forming a 
complex which serves as a target for various conventional 
anticancer drugs that inhibit cancer cell proliferation. 
However, this leads to negative consequences for normal 
cells. Genotoxic agents that target this enzyme-DNA 
complex are known as ‘topoisomerase poisons’. In 
addition, topoisomerase catalytic inhibitors reduce catalytic 
turnover of topoisomerase. Well known examples of 
eukaryotic topoisomerase II poisons include podophyllotoxin 
derivatives (etoposide and teniposide), doxorubicin 
and fluoroquinolones (Pommier, 2013). Phytochemicals 
such as curcumin, resveratrol, EGCG and isothiocyanates 
have also been reported to act as topoisomerase 
poisons and catalytic inhibitors. 
Lactate dehydrogenase (LDH) which catalyzes the 
synthesis of lactate from pyruvate under anaerobic conditions 
is vital for cancer cells as it shunts oxidative 
phosphorylation to lactate in the hypoxic tumor 
microenvironment. LDH-A is one of the two isoforms 
of LDH, which converts pyruvate to lactate and is 
overexpressed in cancer cells. LDH-A is a downstream 
target of HIF1 , promoting lactic acid fermentation to 
generate nicotinamide adenine dinucleotide (NAD+) in 
hypoxic conditions that is essential for cancer cell 
glycolysis. LDH-A knockdown experiments demonstrated 
activation of the mitochondrial respiratory pathway in 
cancer cells, which results in repression of tumor 
progression (Miao et al, 2013). Some plant extracts 
have been screened to discover their potential in 
inhibiting LDH, which can serve as an anticancer 
target (Deiab et al, 2014). For example, Rhus chinensis 
was discovered to be a potent LDH inhibitor, which 
decreases the viability of tumor cells. 
Apoptosis pathway is an important target of 
plant metabolites 
Apoptosis is an energy-dependent programmed cell 
death, which maintains the homeostatic balance 
between cell proliferation and cell death. Homeostasis 
is lost in cancer because the apoptotic mechanism is 
suppressed through various mechanisms (Hanahan 
and Weinberg, 2011). Many natural anticancer agents 
have been shown to induce the apoptotic pathway 
directly or activate apoptosis as a final step in the 
process. The characteristic features of an apoptotic 
cell are cell shrinkage, pyknosis and karyorrhexis 
(nuclear fragmentation). There is another passive 
process of cell death called necrosis that is energy 
independent. A thin line of difference exists between 
these two processes. Researchers on various occasions 
have found these two processes to be regulated by a 
common network of pathways (Nikoletopoulou et al, 
2013). The determination of cell death by apoptosis or 
necrosis is dependent on the cell death signal, the 
developmental stage and the type of cell. Vascular 
disrupting agents that disrupt established tumor 
vasculature are found to promote the necrotic death of 
tumor (Kretzschmann and Furst, 2014). 
Apoptosis is grouped into three steps: initiation, 
execution and engulfment phases. Each step is regulated 
by caspases. Caspases 2, 8, 9 and 10 perform the 
initiation phase, and caspases 3, 6 and 7 perform the 
execution phase (Green and Llambi, 2015). Once a 
single caspase is activated, it initiates a cascade of 
activation of other procaspases starting the apoptosis 
process. Various plant metabolites that directly 
activate either the initiator caspases or the execution 
caspases. Quercetin, a well-known flavonoid, induces 
apoptosis in cancer cells through the activation of 
caspases 3 and 7 (Khan et al, 2016). Luteolin, a flavonoid 
found in broccoli, celery and carrots, induces apoptosis 
in various cancer cell lines through the activation of 
caspases 3, 8, 9 and 10 (Horinaka et al, 2005). Phytic 
acids in rice and rice bran have been shown to enhance the 
expression of caspases 3 and 8 in colon and liver 
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cancer cells (Shafie et al, 2013; Al-Fatlawi et al, 2014). 
Rice tocotrienols (gamma/delta) also activate caspase 
3, leading to apoptosis in cancer cells (Yu et al, 2019). 
Two pathways, extrinsic (death receptor pathway) 
and intrinsic (mitochondrial pathway), are responsible 
for initiating apoptosis (Fig. 2). Both pathways are 
dependent on each other for their regulation and 
activation (Pfeffer and Singh, 2018). The activation of 
a caspase cascade is a hallmark of apoptosis. The 
extrinsic pathway begins with the expression of 
various death receptors on the surface of the cells such 
as fas ligand (FASL), tumor necrosis factor (TNF) and 
tumor necrosis factor related apoptosis-inducing ligand 
(TRAIL). These receptors transmit signals from the 
surface to the intracellular signaling pathway. Binding 
of ligand to these receptors activates procaspase 8. 
Plant extracts have been reported to exert an 
anticancer effect by increasing the expression of death 
receptors on cancer cells. For example, O. majorana 
extract, rich in phenolic terpenoids, flavonoids, tannins, 
hydroquinone, phenolic glycosides and triterpenoids, 
is found to induce apoptosis via upregulation of 
TNF-  and has been reported to induce apoptosis in 
ovarian cancer cells by increasing TRAIL (Yi et al, 
2014). Luteolin, a flavonoid found in several plants, 
can enhance expression of death receptors and death 
receptor downstream factors such as FASL, TRAIL 
and fas-associated death domain (FADD) proteins in 
HeLa cells (Ham et al, 2014). 
The intrinsic pathway is initiated via various 
mitochondrial initiated events. These events include 
an increase in mitochondrial membrane permeability, 
depletion of transmembrane potential and release of 
proapoptotic proteins like cytochrome C, second 
mitochondria-derived activator of caspases (SMAC) 
and serine protease, a high-temperature requirement 
protein A2 (HtrA2/Omi) (Pfeffer and Singh, 2018). 
These proapoptotic proteins activate procaspase 9 and 
apoptotic protease-activating factor-1 (APAF-1). Several 
plant metabolites have been reported to initiate apoptosis 
Fig. 2. Initiation phase of apoptosis and their regulation by plant metabolites.  
Both pathways (extrinsic and intrinsic) result in the formation of an apoptotic body, which is a diagnostic biomarker of apoptosis. Curcumin,
delphinidin and malvidin regulate both intrinsic and extrinsic pathways. Adapted from Kuppusamy et al (2013). 
APAF-1, Apoptotic protease activating factor-1; Cyt C, Cytochrome C; FADD, FAS-associated death domain; FASL, Fas ligand; FLIP, FADD-like
Interleukin-1beta-converting enzyme inhibitory protein; TNF, Tumor necrosis factor; TRAIL, TNF-related apoptosis inducing ligand; XIAP, X-linked
inhibitor of apoptosis. 
20                                                                          Rice Science, Vol. 28, No. 1, 2021
in cancer cells by mitochondrial perturbations (Cincin 
et al, 2015; Green and Llambi, 2015; Zeng et al, 2018). 
For example, betulinic acid, a pentacyclic triterpenoid 
found in the bark of white-birched trees, activates 
apoptotic cell death by decreasing mitochondrial potential 
and increasing permeability with no effect on normal 
proliferating cells. This characteristic makes betulinic 
acid a promising anticancer agent. Quercetin can also 
induce apoptosis in DLD-1 colon cancer cell line by 
decreasing the mitochondrial membrane potential. 
Bcl-2 (B-cell lymphoma 2) family members are rich 
in pro- and anti-apoptotic proteins, which mainly regulate 
apoptotic processes associated with mitochondria. 
Anti-apoptotic proteins include Bcl2, Bcl-x, Bcl-XL 
(B-cell lymphoma-extra large) and AKT-1 that inhibit 
apoptosis by preventing caspase activation (Green and 
Llambi, 2015). Pro-apoptotic proteins include Bcl-10, 
Bax (BCL2-associated X protein), Bak (Bcl-2 homologous 
antagonist/killer), and Bid (BH3 interacting-domain 
death agonist). Phytic acid in rice bran enhances Bax 
protein and reduces Bcl-XL protein in colorectal and 
liver cancer cells (Shafie et al, 2013; Al-Fatlawi et al, 
2014). Quercetin has been documented to induce 
apoptosis in cancer cells through the inhibition of 
activation of PI3K/Akt/mTOR (Rivera et al, 2016). It 
also increases the expressions of Bax, Bad and Bcl-10. 
Other pro-apoptotic proteins that initiate apoptosis in a 
caspase-independent manner include apoptosis-inducing 
factor (AIF) and caspase activated DNase (CAD). Once 
released, these proteins are translocated to the nucleus 
causing DNA fragmentation, which can initiate the 
apoptotic pathway (Green and Llambi, 2015). Some 
bioactive compounds of plants, such as magnolol, a 
hydroxylated biphenyl, are reported to induce apoptosis 
in non-small cell lung cancer by DNA fragmentation 
and release of Bid, Bax and cytochrome C. 
The execution pathway is the second phase of 
apoptosis after the initiation phase. It is activated by 
caspases 8, 9 and 10, and mediated by caspases 3, 6 
and 7. Execution pathway is characterized by the degradation 
of the nuclear particle, nucleus and cytoskeletal proteins. 
Caspase 3 on activation inhibits the suppression of 
endonuclease CAD by ICAD. CAD on activation 
degrades DNA and condenses chromatin. Even though 
it is the second important step of apoptosis, no plant 
metabolites have been reported to activate the execution 
phase of apoptosis in cancer cells. 
The final stage of apoptosis is the engulfment of the 
apoptotic cell by phagocytes. This is mediated by the 
attraction of phagocytes through the externalization of 
phosphatidylserine on the surface of apoptotic cells by 
a member of tumor necrosis factor receptor superfamily 
6 (FAS), caspase 8 and caspase 3 (Green and Llambi, 
2015). Although plant metabolites (berberine, ursolic 
acid, malvidin, curcumin, etc.) have been shown to 
exert an anticancer effect by apoptosis on various 
cancer cell lines by activating the initiation phase, there 
is a need for more research to determine the effect of 
these compounds on the execution and engulfment 
phase of apoptosis. Extensive study to see the effects 
of these compounds on normal proliferating cells 
should be performed to verify whether the anticancer 
effect is efficient for proceeding to clinical trials. 
Plant metabolites target angiogenic property 
associated with cancer 
Pathologically initiated angiogenesis is a hallmark of 
cancer. As cancer progresses, cell proliferation exceeds 
cell death to a point where tumor cells further away 
from blood circulation suffering severe nutrition and 
oxygen insufficiency. Tumor cells can overcome the 
insufficiency by creating new blood vessels from 
existing ones by releasing various factors that directly 
or indirectly induce angiogenesis through proliferation 
and differentiation of endothelial cells. This phenomenon 
is called ‘angiogenic switch’ (Al-Abd et al, 2017). The 
angiogenic switch is followed by degradation of extra- 
cellular matrix and endothelial migrations. Various VEGF 
and angiopoietin (Ang) family members are involved in 
the process. Genes encoding VEGF are up-regulated 
due to hypoxia and signals from several oncogenes 
such as Ras and Myc. VEGF-A is considered to be the 
major regulator of angiogenesis which binds specific 
tyrosine kinase-like receptors that are upregulated in 
various cancers. Several plant metabolites like flavonoids, 
tannins, triterpenoids and sulphated carbohydrates 
inhibit angiogenesis in cancer cells (Wang et al, 2014). 
Polymethoxylated flavonoids in citrus fruits are 
shown to have anti-angiogenic activity in cancer cells 
(Cirmi et al, 2016). Betulinic acid has been reported to 
inhibit aminopeptidase N enzyme that is overexpressed in 
various cancers and is involved in the regulation of 
angiogenesis (Fulda, 2008). Plant extracts are efficient 
vascular disrupting agents of tumors. They can be 
subdivided into two classes: ligand directed agents, 
which include various antibodies and factors targeting 
endothelial receptors, and small molecule agents, 
which include various flavonoids and tubulin-binding 
agents (Kretzschmann and Furst, 2014). 
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Targeting microtubules for cancer prevention 
by plant metabolites 
Microtubules (MT) are essential structures in the 
cytoskeleton of the cell, composed of  tubulins. 
They are involved in cell division and possess various 
motility and signaling functions. They help in segregation 
of chromosomes and separation into daughter cells 
during mitosis. Aberration in their assembly and 
function causes abnormal cell division, cell arrest and 
apoptosis. These integral functions make them an 
important target for inhibiting division of cancer cell. 
Agents targeting microtubules in cancer cells can be 
divided into two categories: MT-stabilizing and 
destabilizing agents (Bates and Eastman, 2017). 
Various microtubule-associated proteins (MAP) help 
in regulating the dynamics of microtubules which can 
serve as a potential target for inhibiting microtubules. 
Although synthetic and semi-synthetic derivatives of 
plant compounds are currently used to treat cancer, 
their anti-proliferative effects on normal cells along 
with cancer cells result in detrimental adverse side 
effects. These include commercially prescribed cancer 
drugs, paclitaxel, vincristine and vinblastine. It has 
been hypothesized that derivatization and purification 
of plant extract to a single compound make it more 
toxic because of no synergistic interactions of different 
compounds present in the plant. Plant extracts have 
been reported to be more efficient with less toxicity to 
normal cells (Iqbal et al, 2017). For instance, Cortex 
mori extract has been reported to bind tubulins of 
microtubules inhibiting its assembly and ultimately 
inducing apoptosis (Nam et al, 2002).  
Plant natural compounds in clinical trials  
Several plant natural compounds or their derivatives 
that do not belong to the classical anticancer compounds 
(vinblastine/vincristine, camptothecin, paclitaxel and 
podophyllotoxin) are in various stages of clinical trials 
(Pan et al, 2012). Hemoharringtonine (alkaloid ester) 
is approved for use in the treatment of chronic 
myeloid leukemia, especially in patients who are 
resistant to the treatment of tyrosine kinase inhibitors 
(Seca and Pinto, 2018). Several clinical trials are in 
progress as single and combined therapies with 
hemoharringtonine for different cancers. Ingenol 
mebutate isolated from Euphorbia sp. has been shown 
to have cytotoxic as well as immune-modulatory 
effects due to loss of mitochondrial membrane potential 
(Ogbourne and Parsons, 2014). It has been approved 
as a drug for keratosis, a precancerous condition and is 
under phase I/II clinical trials for skin cancer treatment. 
Several clinical studies have been conducted with 
curcumin and are in progress in combination with other 
anticancer drugs due to its role as a chemosensitizer 
(Gupta et al, 2013; Seca and Pinto, 2018). Betulinic 
acid is a triterpene presents in many plants in low 
quantities. Betulin is present in large quantity in birch 
bark. It can be converted to betulinic acid which is an 
effective anticancer agent against a wide range of 
cancer types (Ali-Seyed et al, 2016). Betulinic acid 
and combretastatin are in phase I/II clinical trials as 
anticancer agents. Indigo (indole alkaloid) derivative 
is in a clinical trial for chronic myeloid leukemia. Lycopene 
and resveratrol have shown promising results in 
clinical trials for prostate cancer and colon cancer, 
respectively (Sahin et al, 2017; Alam et al, 2018). 
Plant callus suspension culture as a tool for 
production of anticancer compounds 
Isolation of natural products extracted directly from 
plants has limitations such as dependence on the 
availability of space, soil and environmental conditions as 
well as the effect of extraction and purification 
processes on the yield and stability of metabolites. 
Moreover, production and isolation of chemicals or 
natural compounds from rare or endangered medicinal 
plants using conventional techniques from plant parts 
are not possible. The initial overexploitation of Taxus
brevifolia for the production of paclitaxel has resulted 
in the declaration of the plant as near threatened 
(Howes, 2018). The production of secondary metabolites 
from plant cells via in vitro techniques under aseptic 
conditions has the potential of providing an unlimited 
supply of targeted compounds (Veeresham and Chitti, 
2013). Plant cell cultures are being used for the 
production of not only anticancer compounds but also 
biopharmaceuticals including therapeutic antibodies 
for other diseases (Efferth, 2019). Callus is an 
undifferentiated mass of totipotent cells. Callus 
extracts have been reported to give superior results 
compared to extracts from plant parts as seen in the 
case of Aegle marmelos callus extract which lowered 
blood sugar level of diabetic rabbits more efficiently 
than leaf extract (Arumugam et al, 2008). Furthermore, 
callus extract is shown to be as efficient as leaf extract 
of stone apple (Aegle marmelos) and miracle fruit 
(Gymnema sylvestre) in lowering blood sugar levels of 
diabetic rabbits (Arumugam et al, 2008; Ahmed et al, 
2010). Comparison of callus cultures and plant 
extracts identi ed higher antioxidant activity in callus 
cultures (Hakkim et al, 2007). A callus suspension 
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culture is made by growing callus in liquid plant 
growth medium for three weeks. During this period, 
they start releasing their secondary metabolites. The 
secondary metabolites could also be part of the cells. 
Callus suspension cultures unlike plant parts offer the 
advantage of providing an unlimited supply of compounds. 
Due to rapid growth cycles of cell suspension cultures, 
they are generally used for the large-scale production 
of bioactive secondary metabolites such as paclitaxel, 
vinblastine and vincristine (Vanisree et al, 2004; 
Georgiev and Maciuk, 2009). Plant cell cultures have 
been employed for the production of anticancer 
compounds, resveratrol from Arachis hypogea callus 
culture (Nandagopal et al, 2017). Aralin, a cytotoxic 
lectin produced from Aralia elata callus culture shows 
2-fold higher activity than the compound isolated from 
plant part due to glycosylation (Tomatsu et al, 2004). The 
production of an antiproliferative furanoheliangolide 
was reported in Lychnophora ericoides callus culture 
(dos Santos et al, 2004). Rosmarinic acid and 
salvianolic acid B produced from callus culture of the 
Chinese medicinal plant, Salvia miltiorrhiza, show 
cytotoxic activity against acute lymphoblastic leukemia 
(Wu et al, 2016). Rice cell suspension cultures have 
been used to produce human 1-antitrypsin, serum 
albumin, lysozyme, interleukin-12 (IL-12) and a 
cytokine, granulocyte-macrophage colony stimulating 
factor (Xu et al, 2011; Santos et al, 2016). Rice cell 
cultures give higher expression of human IL-12 and 
lower proteolytic activity compared to other plant 
cells (Shin et al, 2010). The high levels of expression 
in the rice cell culture system are achieved in most 
cases by the use of an inducible rice -amylase 3D 
(RAmy3D) promoter. The production of specific 
compounds in callus cultures can be enhanced by 
adding elicitors. This is based on the principle that 
plants increase the production of specific secondary 
metabolites when subjected to abiotic (drought, salt, 
heat, cold and heavy metal, etc.) or biotic (bacteria, 
fungi, virus, and nematodes, etc.) stress which act as 
external elicitors for inducing gene expression directly 
or indirectly. A number of abiotic and biotic elicitors 
enhance the production of vinca alkaloids in 
Catharanthus roseus cell cultures (Siddiqui et al, 
2013). Paclitaxel production increases 2-fold using an 
endophytic fungus (Aspergillus niger) of Taxus
chinensis as an elicitor in callus culture of T. chinensis 
(Wang et al, 2001). In another study, methyl jasmonate is 
found to enhance paclitaxel levels in Taxus baccata 
callus suspension culture (Tabata, 2004). The addition 
of methyl jasmonate doubles the production of 
shikonin derivatives with antitumor activity in callus 
culture of Arnebia euchroma (Hao et al, 2014). The 
production of camptothecin in Camptotheca acuminata 
cell culture increases 11-fold by UV-B light, and 
10-hydroxycamptothecin increases 25-fold by salicylic 
acid (Pi et al, 2010). 
Plant callus suspension culture as a 
promising anticancer agent 
There are only a few studies where plant callus 
suspension culture or their extracts were evaluated for 
their cytotoxic activity. The methanol extract of callus 
suspension culture of green tea (Camellia sinensis) 
inhibits growth (64%) of the human cervix carcinoma 
cell line, HEP-2 (Choi et al, 2006). Two flavones, 
echioidinin and 7-O-methywogonin, isolated from the 
callus culture of a medicinal plant Andrographis 
lineata, show cytotoxicity on a leukemic cell line 
(Mohammed et al, 2015). However, this study did not 
use the callus culture for cytotoxicity studies. In 
another study, the methanol extract of Echinacea 
purpurea callus treated with ZnO nanoparticles show 
an increase in flavonoid content and cytotoxic activity 
on the breast cancer cell line MCF-7 (Karimi et al, 
2018). Cytotoxic activity of rice callus suspension 
culture (RCSC) was reported for the first time in renal 
and colon cancer cell lines where up to 95% decrease 
in cell viability was observed with no significant 
effect on normal lung fibroblast cell line at specific 
dilutions of RCSC (Fig. 3; Deshpande et al, 2012). 
Cytotoxic activity of RCSC was found to be as 
effective as Taxol but without the side effects of 
killing normal cells. Further extension of this study 
showed similar effects on lung and breast cancer cell 
lines where lung cancer cell lines show better response 
compared to the other cancer cell lines (Rahman et al, 
2016). The extent of inhibition in cell proliferation by 
RCSC in metastatic colon cancer cell line is much 
greater than non-metastatic colon cancer cell line. A 
differential response was also observed in breast 
cancer cell lines where the hormone-dependent cell 
line shows a better response to RCSC than the hormone- 
independent cell line. It is likely that specific RCSC 
compounds may directly or indirectly inhibit the 
binding of estrogen to receptors on breast cancer cells. 
Molecular and cellular mechanisms involved 
in cytotoxic activity of RCSC 
Previous studies showed high levels of LDH in cancer 
cells, which can be attributed to the Warburg effect 
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where high rates of glycolysis drive pyruvate to lactic 
acid fermentation. Treatment with RCSC reduces the 
total cellular LDH levels about 90% in colon and lung 
cancer cell lines, which is a positive attribute for its 
anticancer activity (Rahman et al, 2016). RCSC- 
treated lung cancer cell lines show evidence of 
apoptotic changes based on analysis of caspases 3 and 
7, which are involved in the execution phase of 
apoptosis. RCSC affects membrane integrity of cancer 
cells but not normal cells. Real-time PCR analysis 
identi ed the upregulation of genes involved in apoptosis 
and cell cycle inhibition and down-regulation of 
cancer-promoting genes. A gene encoding FASLG 
protein, which is a member of the tumor necrosis 
factor superfamily with a role in apoptosis, is up- 
regulated. A surprising finding is the up-regulation of 
a proto-oncogene, c-Jun, which is related to the 
PI3K-AKT pathway. Some studies have shown the 
role of c-Jun in apoptosis via alternate signaling 
pathways involving c-Jun N-terminal protein kinase 
(JNK) as demonstrated in the cytotoxic activity of 
tylophorine, an alkaloid from the medicinal plant, 
Tylophora indica (Andrianantoandro, 2012; Yang et al, 
2013). The cytotoxic activity of grape seed extract is 
attributed to apoptosis mediated by JNK (Tyagi et al, 
2003). The levels of most integrins increase in cancer 
cells due to their roles in tyrosine kinase signaling 
which regulates proliferation and adhesion of cells. 
However, two integrins, 2  (ITGA2B) and 3 (ITGB3), 
which are expressed at lower levels in cancer cells, are 
up-regulated on RCSC treatment. Up-regulation of 
ITGB3 is shown to suppress the malignant tumors 
(Kaur et al, 2009). The molecular mechanism proposed 
for the cytotoxic activity of RCSC is shown in Fig. 4. 
Scanning electron microscopy analysis shows flatter 
morphology of the cancer cells treated with RCSC, 
indicating that they are not at mitosis (Fig. 4; Rahman 
et al, 2016). Furthermore, sizes of cells are more 
homogeneous than control, suggesting that these cells 
are controlled by cell cycle checkpoints. Cells are 
better attached to each other, suggesting the possible 
alterations of cell junctions.  
Double role of RCSC as a cytotoxic and 
anti-inflammatory agent 
The potential of RCSC to act as an anti-inflammatory 
agent was shown in three human normal colon cell 
lines by the treatment with proinflammatory cytokines 
followed by RCSC (Driscoll et al, 2019). RCSC, its 
concentrates and its bioactive fractions not only show 
anti-inflammatory activity in an in vitro inflammatory 
bowel disease model but also display cytotoxic 
Fig. 3. Effects of rice callus suspension culture (RCSC) and Taxol® on normal and cancer cells. 
RCSC reduces the viability of cancer cells with minimal or no effect on the normal cells compared to Taxol® based on Deshpande et al (2012) and
Rahman et al (2016). 
24                                                                          Rice Science, Vol. 28, No. 1, 2021
activity on a colon cancer cell line. This is likely due 
to the regulation of cross talk and interdependence of 
cancer and inflammation/ROS mediated by RCSC. 
The transcription factors NF- B and signal transducer 
and activator of transcription 3 (STAT3) are common 
regulators of cancer and inflammation (Elinav et al, 
2013). In addition to NF- B, C-C motif ligand 5 
(CCL5) and C-X-C motif chemokines (CXCL) which 
are common players between cancer and inflammation 
are differentially regulated by RCSC based on gene 
expression studies. The cross talk between cancer and 
inflammation and the concept that chronic inflammation 
leads to cancer has resulted in the process of development 
of cytokine-based therapies including the use of 
monoclonal antibodies targeted against TNF- , VEGF 
and interleukin-6 (IL-6), and treatment with IL-2 (Qu 
et al, 2018). The above approaches have shown hope 
significant reduction in inflammation as well as 
regression of tumors. The cross talk and the underlying 
molecular mechanisms employed by RCSC can be 
studied using a 3D cell culture system or organoids 
developed from cancer patient tissues which serve as 
in vivo models (Baker, 2018).  
Unexpected bioactive compounds in RCSC 
RCSC isolated fractions employing column chromatography 
and HPLC are shown to harbor anti-inflammatory and 
cytotoxic activity (Driscoll et al, 2019). The bioactive 
fractions of RCSC comprise 4-deoxyphloridzin, 
5 -methoxycurcumin, piceid and lupeol (Fig. 3). 
4-deoxyphloridzin is a derivative of phloridzin which 
is abundant in the apple peel. Phloridzin is shown to 
have anti-aging effects in several organisms through 
upregulation of antioxidative enzymes and acting 
against glycation (Xiang et al, 2011). Phloridzin 
inhibits sodium-glucose transporter 1 (SGLT1) and 
glucose facilitative transporter 2 (GLUT2) in Caco 
cells (Manzano and Williamson, 2010). 4-deoxyphloridzin 
in RCSC might inhibit glucose transporters thereby 
limiting cancer cells from utilizing glucose as an 
energy source. 5 -methoxycurcumin is a natural derivative 
of curcumin, which is a well-known anticancer, 
antioxidant and anti-inflammatory agent. Piceid is a 
glycoside form of resveratrol from which resveratrol 
is synthesized naturally. It is abundant in grapes and 
red wine among others. Piceid shows tumor cell 
cytotoxicity as well as higher radical scavenging 
activity compared to resveratrol (Su et al, 2013). The 
presence of piceid in RCSC is surprising as rice does 
not have piceid or resveratrol but transgenic plants 
which produce piceid or resveratrol have been 
reported (Baek et al, 2013). Lupeol is a triterpenoid 
found naturally in some fruits and vegetables. Lupeol 
is an anticancer and anti-inflammatory agent exerting 
its effect through NF- B and PI3K/Akt signaling 
(Saleem, 2009). Lupeol has been reported in HPLC 
sub-fraction of black rice bran extract which shows 
anti-leukemic activity (Suttiarporn et al, 2015). The 
enzyme, curcuminoid synthase (CUS), a type III 
polyketide synthase, was identified from rice, which 
can synthesize bisdemethoxycurcumin in vitro from 
coumaroyl-CoA and malonyl-CoA (Katsuyama et al, 
2010). The four compounds reported above in RCSC 
are produced during the three weeks of incubation 
involved in its production and are not present in rice 
tissues or callus in significant quantities.  
Fig. 4. Molecular mechanisms regulating cytotoxic
activity of rice callus suspension culture
(RCSC).  
RCSC upregulates the transcription factor,
NF- B, which induces the production of the
tumor necrosis factor, FASLG, leading to
apoptosis via extrinsic pathway. Up-regulation
of c-Jun leads to downregulation of cyclins and
cyclin-dependent kinases, resulting in apoptosis
via intrinsic pathway. c-Jun has also been
shown to upregulate NF- B. RCSC increases
ROS levels in cancer cells, leading to DNA
damage and loss of membrane integrity.
CCND3, Cyclin D3; CDK, Cyclin-dependent
kinase; c-Jun, Cellular protooncogene; FASLG,
Tumor necrosis factor ligand superfamily
member 6; NF- B, Nuclear factor kappa light
chain enhancer of activated B cells; LDH,
Lactate dehydrogenase; ROS, Reactive oxygen
species. 
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Popular anticancer compounds, often water- 
insoluble, have low bioavailability and short half-life, 
which limits their application for cancer treatment 
(Fridlender et al, 2015). For instance, paclitaxel and 
curcumin are water insoluble. Some natural compounds 
have limited absorption in the intestines and liver. 
Semisynthetic soluble analogs have been developed to 
overcome the above limitations. Further, nanoparticles 
and liposomes have been developed as drug carriers 
for plant natural products (Karimi et al, 2018; Shishir 
et al, 2019). Liposome-mediated treatment with curcumin 
enhances cytotoxicity in a skin cancer cell line, breast 
cancer cell lines, and human glioma cells transplanted 
in mice (Karewicz et al, 2013; Kangarlou et al, 2017; 
Zhao et al, 2018). Nanoparticles have been used to 
enhance the bioavailability of curcumin, epigallocatechin 
gallate (EGCG) and quercetin (Watkins et al, 2015). 
For instance, poly (lactic-co-glycolic acid) nanoparticles 
enhance bioavailability of curcumin to 5.6-fold and 
lipid nanoparticles to 9.4-fold compared to curcumin 
alone (Xie et al, 2011; Ji et al, 2016). Similar issues of 
bioavailability and short half-life as observed with 
curcumin, EGCG and resveratrol may be encountered 
with compounds isolated from plant callus suspension 
culture.  
The best way forward for the use of plant callus 
suspension culture and RCSC for anticancer therapy 
depends on several factors. If the pharamacological 
activity of purified bioactive compounds is lower than 
RCSC, semisynthetic analogs of compounds or a 
combination of two or more compounds have to be 
evaluated along with different drug delivery options. 
If none of the above approaches work, the holistic 
approach of employing RCSC as an anticancer agent 
needs to be evaluated, which is similar to the principle 
of Ayurveda, where a mixture of compounds is used 
for the treatment of different ailments. An essential 
criterion to consider in all of the above approaches is 
the presence of cytotoxic activity on cancer cells with 
no effect on normal cells.  
Large scale production of specific 
compounds in callus suspension cultures for 
development of drugs for cancer and other 
diseases: Drawbacks and challenges 
Large scale production of compounds using plant 
callus suspension cultures can be achieved by cell line 
selection, optimization of culture conditions and use 
of elicitors among others (Ochoa-Villarreal et al, 
2016). Anticancer compounds which are manufactured by 
companies using plant suspension cultures include 
paclitaxel by Phyton Biotech, Germany, berberines by 
Mitsui chemicals, and podophyllotoxin by Nippon Oil, 
Japan. The design and operation of bioreactors for 
commercial production in plant suspension culture 
have to consider the cell size, number and shearing 
(Wilson and Roberts, 2012). It is also important to 
consider the location of the compound(s), cell wall, 
vacuole or extracellular so that a suitable strategy can 
be designed for its isolation. Similar approaches can 
be used for the production of specific compounds 
from RCSC and medicinal plant callus suspension 
cultures using different elicitors such as chitosan, 
ethylene, jasmonate derivatives, sodium chloride and 
vanadyl sulfate. If diseases other than cancer respond 
to RCSC or medicinal plant callus suspension cultures, 
a similar approach described above and bioreactors 
can be used for large scale production of bioactive 
phytochemicals and callus cultures. Another alternate 
method is the upregulation of gene(s) regulating specific 
metabolites in callus culture through transgenic approaches.  
Mammalian and microbial cells are being used for 
the production of biopharmaceuticals at least 20 years 
more than plant cell cultures (Santos et al, 2016). This 
gave them a distinct advantage with reference to 
optimization of strains, culture/fermentation conditions 
and design of bioreactors, which results in higher 
yield of natural compounds compared to plant cell 
cultures. Downstream processing includes releasing cellular 
components by breaking cell membranes which may 
release biomacromolecules (such as proteases) that 
destroy biologically active molecules is a drawback in 
using plant cell cultures (Buyel et al, 2015). Upstream 
processing includes the design of bioreactors based on 
the volume of the culture and the fermentation process 
to be used. Continuous fermentation process of 
perfusion type is used for plant cell cultures as it is 
superior to batch and fed-batch due to its dynamic 
nature where fresh media is added with simultaneous 
removal of cell free broth. Chemostat method of 
continuous fermentation process where broth with 
cells is removed accompanied with the addition of 
fresh media is also suitable for plant cell cultures. A 
major challenge in large scale production of secondary 
metabolites is to prevent microbial contamination in 
the bioreactor, which can be accomplished by 
maintaining sterile conditions and the use of antibiotics, if 
needed. The production of other compounds may 
inhibit the production of the targeted compound and 
its isolation. The required metabolite may be produced 
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in low quantities compared to plant parts or it may be 
produced in large quantities without any biological 
activity. Further, secondary metabolite production is 
reduced with the age of the culture. Cells tend to 
aggregate in plant cell culture which require constant 
stirring often at high speed and may result in cell 
damage. There are regulatory issues that need to be 
addressed. These include quality control of the 
products, animal testing for toxicity analysis and as a 
drug followed by clinical trials. Commercial plant cell 
culture platforms for the production of drugs are not 
widely established due to the above concerns, which 
may be alleviated in the future.  
Perspectives 
Plant compounds show promising prospects in 
developing effective drugs in treating cancer. It is 
evident that these components function through different 
mechanisms such as altering microtubules, inducing 
apoptotic signals and inhibiting metabolic enzymes. 
These experimental observations can be used to 
characterize the inhibitory effects of plant bioactive 
compounds on cancer cells. It is essential to distinguish 
the fine line between the normal proliferating cells and 
cancer cells so that a target can be identified without 
damaging normal cell physiology. Plant callus suspension 
cultures have the potential to be new frontiers for the 
production of compounds with anticancer activity. 
Success stories exist for the large sacle production of 
paclitaxel, berberines and podophyllotoxin using plant 
cell cultures in bioreactors. Plant callus suspension 
culture as exemplified by RCSC showed a highly 
desirable trait of selective killing of cancer cells. 
Although our studies with RCSC on cancer cell lines 
are promising, further studies are needed to understand 
genes, proteins, metabolites and interactions between 
macromolecules responsible for the biological activity 
of RCSC. These studies have to be expanded to 
animal model followed by clinical trials. The next step 
would be to evaluate callus suspension cultures of 
various medicinal plants for their anticancer activity. 
If callus suspension cultures and its constituents show 
the ability to arrest the proliferation of cancer cells 
belonging to multiple cancer types with no effect on 
the normal cells, it would be a boon for cancer 
treatment in the future. 
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